NHS Framework - Blood Disorders including Haemophilia A and B - July 2024

Tender description

Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024<br/><br/>Offer reference number: CM/PHS/22/5661<br/><br/>Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 14 months.<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Lot 1: CM/PHS/22/5661/01 Standard Half-life Recombinant Factor VIII Standard Half-life Recombinant Factor VIII Lot 2: CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII Lot 3: CM/PHS/22/5661/03 Emicizumab CM/PHS/22/5661/03 Emicizumab Lot 4: CM/PHS/22/5661/04 eftrenonacog alfa (rFIX EHL) CM/PHS/22/5661/04 eftrenonacog alfa (rFIX EHL) Lot 5: CM/PHS/22/5661/05 albutrepenonacog alfa (rFIX EHL) CM/PHS/22/5661/05 albutrepenonacog alfa (rFIX EHL) Lot 6: CM/PHS/22/5661/06 nonacog beta pegol (rFIX EHL) CM/PHS/22/5661/06 nonacog beta pegol (rFIX EHL) Lot 7: CM/PHS/22/5661/07 rFIX - Standard Half Life CM/PHS/22/5661/07 rFIX - Standard Half Life Lot 8: CM/PHS/22/5661/08 Recombinant Factor VII CM/PHS/22/5661/08 Recombinant Factor VII Lot 9: CM/PHS/22/5661/09 Porcine Factor VIII - susoctocog alfa CM/PHS/22/5661/09 Porcine Factor VIII - susoctocog alfa Lot 10: CM/PHS/22/5661/10 Factor VIII Inhibitor Bypassing Fraction CM/PHS/22/5661/10 Factor VIII Inhibitor Bypassing Fraction Lot 11: CM/PHS/22/5661/11 Factor IX - High Purity Factor IX CM/PHS/22/5661/11 Factor IX - High Purity Factor IX Lot 12: CM/PHS/22/5661/12 Factor X CM/PHS/22/5661/12 Factor X Lot 13: CM/PHS/22/5661/13 Factor XIII - Plasma Derived CM/PHS/22/5661/13 Factor XIII - Plasma Derived Lot 14: CM/PHS/22/5661/14 Factor XIII - Recombinant CM/PHS/22/5661/14 Factor XIII - Recombinant Lot 15: CM/PHS/22/5661/15 Von willebrands factor / Factor VIII CM/PHS/22/5661/15 Von willebrands factor / Factor VIII Lot 16: CM/PHS/22/5661/16 Von willebrands factor - Plasma Derived CM/PHS/22/5661/16 Von willebrands factor - Plasma Derived Lot 17: CM/PHS/22/5661/17 Von willebrands factor - Recombinant CM/PHS/22/5661/17 Von willebrands factor - Recombinant Lot 18: CM/PHS/22/5661/18 Fibrinogen Concentrate CM/PHS/22/5661/18 Fibrinogen Concentrate Lot 19: CM/PHS/22/5661/19 Prothrombin Complex dried CM/PHS/22/5661/19 Prothrombin Complex dried Lot 20: CM/PHS/22/5661/20 Protein C Concentrate CM/PHS/22/5661/20 Protein C Concentrate Lot 21: CM/PHS/22/5661/21 Fresh Frozen Plasma (all blood groups) CM/PHS/22/5561/21 Fresh Frozen Plasma (all blood groups) Lot 22: CM/PHS/22/5661/22 Freeze Dried Plasma CM/PHS/22/5661/22 Freeze Dried Plasma Lot 23: CM/PHS/22/5661/23 Caplacizumab CM/PHS/22/5661/23 Caplacizumab